MXPA04002099A - Composiciones medicinales para neuropatia diabetica. - Google Patents

Composiciones medicinales para neuropatia diabetica.

Info

Publication number
MXPA04002099A
MXPA04002099A MXPA04002099A MXPA04002099A MXPA04002099A MX PA04002099 A MXPA04002099 A MX PA04002099A MX PA04002099 A MXPA04002099 A MX PA04002099A MX PA04002099 A MXPA04002099 A MX PA04002099A MX PA04002099 A MXPA04002099 A MX PA04002099A
Authority
MX
Mexico
Prior art keywords
neuropathy
diabetic neuropathy
medicinal compositions
preventives
cdp
Prior art date
Application number
MXPA04002099A
Other languages
English (en)
Inventor
Kamei Junzo
Original Assignee
Yamasa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Corp filed Critical Yamasa Corp
Publication of MXPA04002099A publication Critical patent/MXPA04002099A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Preventivos/remedios para neuropatia diabetica que contienen citidina 5'-difosfocolina (CDP-colina) como el ingrediente activo; estos preventivos/remedios para neuropatia diabetica, son eficaces contra la neuropatia principalmente provocada por errores metabolicos de hidrocarbonato y tienen alta seguridad; el termino neuropatia incluye neuropatia periferica y neuropatia autonomica; la CDP-colina es efectiva en la administracion oral tambien.
MXPA04002099A 2001-09-05 2002-09-03 Composiciones medicinales para neuropatia diabetica. MXPA04002099A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001268156 2001-09-05
JP2001340838 2001-11-06
PCT/JP2002/008916 WO2003022290A1 (fr) 2001-09-05 2002-09-03 Compositions pharmaceutiques pour traiter la neuropathie diabetique

Publications (1)

Publication Number Publication Date
MXPA04002099A true MXPA04002099A (es) 2004-06-07

Family

ID=26621670

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002099A MXPA04002099A (es) 2001-09-05 2002-09-03 Composiciones medicinales para neuropatia diabetica.

Country Status (13)

Country Link
US (2) US6924272B2 (es)
EP (1) EP1362593B1 (es)
JP (1) JP3968347B2 (es)
KR (1) KR100740079B1 (es)
CN (1) CN1551778A (es)
AT (1) ATE311891T1 (es)
CA (1) CA2459469A1 (es)
DE (1) DE60207824T2 (es)
EA (1) EA006776B1 (es)
ES (1) ES2249616T3 (es)
HU (1) HU225988B1 (es)
MX (1) MXPA04002099A (es)
WO (1) WO2003022290A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA008179B1 (ru) * 2002-07-11 2007-04-27 Ямаса Корпорейшн Цитидин-5'-дифосфохолин для профилактики или лечения токсической (лекарственно-индуцированной) периферической невропатии
CN1930281A (zh) 2004-03-05 2007-03-14 帝斯曼知识产权资产管理有限公司 用于通过连续灌注和交互切向流来培养细胞的方法
DK2343362T4 (da) 2006-07-14 2024-07-08 Patheon Holdings I B V Forbedret fremgangsmåde til dyrkning af celler
KR100812274B1 (ko) * 2006-10-30 2008-03-13 한양대학교 산학협력단 Ｇ-ｃｓｆ를 유효성분으로 하는 당뇨성 말초신경병 예방 및치료제
US7836540B2 (en) 2007-08-02 2010-11-23 3M Innovative Properties Company Broom with particle capture sheet
ITMI20121223A1 (it) * 2012-07-13 2014-01-14 Gregorio Fabio De Nuova composizione farmacologica comprendente citicolina in combinazione con glicerolo e/o acetazolamide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1188178B (it) * 1985-07-05 1988-01-07 Bioresearch Spa Sali della citidin-difospocolina particolarmente idonei per uso orale
JPH0631306B2 (ja) * 1985-07-12 1994-04-27 武田薬品工業株式会社 シチジン―５′―ジリン酸コリン１水和物結晶の製造法
CA1321994C (en) 1987-10-28 1993-09-07 Reid Von Borstel Acylated uridine and cytidine and uses thereof
AU1944799A (en) * 1997-12-24 1999-07-19 Interneuron Pharmaceuticals, Inc. Hyperhydrated citicoline, process and use
JP2000044472A (ja) 1998-07-30 2000-02-15 Kikkoman Corp 糖尿病性合併症の予防または治療薬剤
US6472378B2 (en) * 1998-08-31 2002-10-29 Pro-Neuron, Inc. Compositions and methods for treatment of mitochondrial diseases

Also Published As

Publication number Publication date
US20040014711A1 (en) 2004-01-22
CA2459469A1 (en) 2003-03-20
DE60207824D1 (de) 2006-01-12
EP1362593B1 (en) 2005-12-07
US20050171051A1 (en) 2005-08-04
ES2249616T3 (es) 2006-04-01
JPWO2003022290A1 (ja) 2004-12-24
EP1362593A1 (en) 2003-11-19
US6924272B2 (en) 2005-08-02
WO2003022290A1 (fr) 2003-03-20
EP1362593A4 (en) 2004-06-30
CN1551778A (zh) 2004-12-01
ATE311891T1 (de) 2005-12-15
DE60207824T2 (de) 2006-07-06
KR100740079B1 (ko) 2007-07-18
JP3968347B2 (ja) 2007-08-29
HU225988B1 (en) 2008-02-28
HUP0401940A2 (hu) 2005-01-28
US7074773B2 (en) 2006-07-11
EA006776B1 (ru) 2006-04-28
KR20040033002A (ko) 2004-04-17
EA200400394A1 (ru) 2004-08-26

Similar Documents

Publication Publication Date Title
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
GEP20022851B (en) Flash-Melt Oral Dosage Formulation
TW355683B (en) Composition containing micronized nebivolol
WO2006133941A3 (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
SG157406A1 (en) Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
GEP20053473B (en) High Potency Dihydroergotamine Compositions
MXPA04007980A (es) Preparado farmaceutico de sabor enmascarado en forma de pelicula o de oblea.
AU1537095A (en) Therapeutic agents containing thyroid hormones
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
CA2238271A1 (en) Pharmaceutical compositions comprising flurbiprofen
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
CA2136404A1 (fr) Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale
IL158668A0 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
BR0211198A (pt) Composições farmacêuticas e seu uso
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
CA2377174A1 (en) Oral administration forms for administering a fixed tramadol and diclofenac combination
WO2003049694A3 (en) Methods of therapy for non-hodgkin's lymphoma
MXPA04002099A (es) Composiciones medicinales para neuropatia diabetica.
BR0313177A (pt) Administração oral de calcitonina
ES2176330T3 (es) Compuestos y composiciones para administracion por inhalacion oral o insuflacion.
YU66202A (sh) Sistem za kontrolisano otpuštanje ciprofloksacina nakon oralne primene u jednoj dnevnoj dozi
BR0014440A (pt) Formulações de liberação controlada oral
BRPI0410374A (pt) composição farmacêutica que compreende valsartano
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide

Legal Events

Date Code Title Description
FG Grant or registration